Suchergebnisse - "Silke Buda"

Author response for 'Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness in Germany—Data From Primary Care and Hospital Sentinel Surveillance'

Autoren: null Annika Erdwiens null Carolin Hackmann null Marianne Wedde et al.

Author response for 'Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network'

Autoren: null Angela M. C. Rose null Francisco Pozo null Iván Martínez‐Baz et al.

Author response for 'Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study'

Autoren: null Marine Maurel null Francisco Pozo null Gloria Pérez‐Gimeno et al.

Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.

Autoren: Antunes, Liliana Rojas‐Castro, Madelyn Lozano, Marcos et al.

Quelle: Influenza & Other Respiratory Viruses; Mar2025, Vol. 19 Issue 3, p1-7, 7p

Schlagwörter: COVID-19 vaccines, VACCINE effectiveness, OLDER people, EUROPEANS, SARS-CoV-2, HOSPITAL care

Geografische Kategorien: EUROPE

Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case–control studies, 2015/16–2023/24.

Autoren: Rose, Angela Mary Catherine Nicolay, Nathalie Mazagatos, Clara et al.

Quelle: BMC Medicine; 11/3/2025, Vol. 23 Issue 1, p1-14, 14p

Schlagwörter: VACCINE effectiveness, CHRONIC diseases, FLU vaccine efficacy, CASE-control method, INFLUENZA, OLDER people

Geografische Kategorien: EUROPE

COVID‐19 Vaccine Effectiveness Against Hospitalization in Older Adults, VEBIS Hospital Network, Europe, September 2024–May 2025.

Autoren: Rojas‐Castro, Madelyn Verdasca, Nuno Monge, Susana et al.

Quelle: Influenza & Other Respiratory Viruses; Nov2025, Vol. 19 Issue 11, p1-8, 8p

Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.

Autoren: Rose, Angela M. C. Pozo, Francisco Martínez‐Baz, Iván et al.

Quelle: Influenza & Other Respiratory Viruses; Feb2024, Vol. 18 Issue 2, p1-9, 9p

Schlagwörter: FLU vaccine efficacy, INFLUENZA, VACCINE effectiveness, SARIS, RESPIRATORY infections, ADULTS

Geografische Kategorien: EUROPE

COVID‐19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS‐CoV‐2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care Network.

Autoren: Laniece Delaunay, Charlotte Verdasca, Nuno Monge, Susana et al.

Quelle: Influenza & Other Respiratory Viruses; May2025, Vol. 19 Issue 5, p1-5, 5p

Schlagwörter: COVID-19, SARS-CoV-2, PRIMARY care, VACCINE effectiveness, VACCINATION status, COHORT analysis, OLDER people

Geografische Kategorien: EUROPE

Impact of the COVID‐19 Pandemic on Influenza Circulation During the 2020/21 and 2021/22 Seasons, in Europe.

Autoren: Sinnathamby, Mary A. Meslé, Margaux M. I. Mook, Piers et al.

Quelle: Influenza & Other Respiratory Viruses; May2024, Vol. 18 Issue 5, p1-15, 15p

Schlagwörter: COVID-19, COVID-19 pandemic, INFLUENZA, SEASONAL influenza, INFLUENZA epidemiology, PRIMARY care

Geografische Kategorien: EUROPE

Contributing authors

Autoren: Viorel Alex Ro Annunziato Ivan Bakoss et al.

Weitere Verfasser: Viorel Alex Ro Annunziato Ivan Bakoss et al.

Quelle: http://www.ecdc.europa.eu/en/publications/Publications/Influenza-Europe-2011-2012-surveillance-report.pdf.

Dateibeschreibung: application/pdf

Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.375.4472

Verfügbarkeit: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.375.4472
http://www.ecdc.europa.eu/en/publications/Publications/Influenza-Europe-2011-2012-surveillance-report.pdf

Think global, act local – eine globale Perspektive auf die Vogelgrippe. (German)

Alternate Title: Think global, act local – a global perspective on avian Influenza. (English)

Autoren: Schilling, Julia Buda, Silke Dürrwald, Ralf et al.

Quelle: Public Health Forum; Sep2025, Vol. 33 Issue 3, p209-212, 4p

Schlagwörter: AVIAN influenza, INFLUENZA A virus, H5N1 subtype, ZOONOSES, HUMAN-animal relationships, INFECTIOUS disease transmission, CRISIS management, WORLD health

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024.

Autoren: Merdrignac, Lore Laniece Delaunay, Charlotte Verdasca, Nuno et al.

Quelle: Influenza & Other Respiratory Viruses; Nov2024, Vol. 18 Issue 11, p1-8, 8p

Schlagwörter: VACCINE effectiveness, OLDER people, SARS-CoV-2 Omicron variant, PRIMARY care, CHRONIC diseases

Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness in Germany—Data From Primary Care and Hospital Sentinel Surveillance.

Autoren: Erdwiens, Annika Hackmann, Carolin Wedde, Marianne et al.

Quelle: Influenza & Other Respiratory Viruses; May2025, Vol. 19 Issue 5, p1-6, 6p

Schlagwörter: VACCINE effectiveness, INFLUENZA, SECONDARY care (Medicine), INFLUENZA B virus, PRIMARY care, SEASONAL influenza, INFLUENZA A virus, H1N1 subtype

Geografische Kategorien: GERMANY

Early COVID‐19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024.

Autoren: Antunes, Liliana Mazagatos, Clara Martínez‐Baz, Iván et al.

Quelle: Influenza & Other Respiratory Viruses; Aug2024, Vol. 18 Issue 8, p1-7, 7p

Schlagwörter: VACCINE effectiveness, SARS-CoV-2 Omicron variant, OLDER people, RESPIRATORY infections, VACCINATION

Geografische Kategorien: EUROPE

Authors' response: Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic.

Autoren: Wei Cai Köndgen, Sophie Tolksdorf, Kristin et al.

Quelle: Eurosurveillance (15607917); 5/16/2024, Vol. 29 Issue 20, p39-40, 2p

Alternating patterns of seasonal influenza activity in the WHO European Region following the 2009 pandemic, 2010‐2018.

Autoren: Mook, Piers Meerhoff, Tamara Olsen, Sonja J. et al.

Quelle: Influenza & Other Respiratory Viruses; Mar2020, Vol. 14 Issue 2, p150-161, 12p

Schlagwörter: SEASONAL influenza, VIRUS diseases, VIRAL variation, PANDEMICS, INFLUENZA A virus, INFLUENZA

Geografische Kategorien: CENTRAL Asia

Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.

Autoren: Maurel, Marine Pozo, Francisco Pérez‐Gimeno, Gloria et al.

Quelle: Influenza & Other Respiratory Viruses; Jan2024, Vol. 18 Issue 1, p1-12, 12p

Schlagwörter: FLU vaccine efficacy, VACCINE effectiveness, PRIMARY care, RESPIRATORY infections, INFLUENZA vaccines, INFLUENZA

Geografische Kategorien: EUROPE

Respiratory viruses dynamics and interactions: ten years of surveillance in central Europe.

Autoren: Horemheb-Rubio, Gibran Eggeling, Ralf Schmeiβer, Norbert et al.

Quelle: BMC Public Health; 6/11/2022, Vol. 22 Issue 1, p1-10, 10p, 1 Diagram, 2 Charts, 2 Graphs, 1 Map

Schlagwörter: VIRUSES, RESPIRATORY infections, VIRUS diseases, MIXED infections, RNA viruses

Erratum to 'Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe – Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18' [Vaccine 35 (2017) 4828–4835]

Autoren: Angeliki Melidou Eeva Broberg Cornelia Adlhoch et al.

Quelle: European region influenza surveillance network 2018, ' Erratum to “Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe – Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18” [Vaccine 35 (2017) 4828–4835] (S0264410X17309659) (10.1016/j.vaccine.2017.07.057)) ', Vaccine, vol. 36, no. 19, pp. 2740-2741 . https://doi.org/10.1016/j.vaccine.2017.12.039

Schlagwörter: 03 medical and health sciences, 0302 clinical medicine, 3. Good health

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/29274700
https://www.ncbi.nlm.nih.gov/pubmed/29274700
https://www.sciencedirect.com/science/article/pii/S0264410X17317929
https://findresearcher.sdu.dk:8443/ws/files/140504012/Erratum_to_Predominance_of_influenza_AH3N2_virus_genetic_subclade_3C.2a1_during_an_early_2016_17_influenza_season_in_Europe.pdf

Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study.

Autoren: Kissling, Esther Pozo, Francisco Martínez‐Baz, Iván et al.

Quelle: Influenza & Other Respiratory Viruses; Jan2023, Vol. 17 Issue 1, p1-10, 10p

Schlagwörter: H1N1 influenza, FLU vaccine efficacy, PRIMARY care, RESPIRATORY infections, INFLUENZA vaccines, INFLUENZA A virus, INFLUENZA

Geografische Kategorien: EUROPE